Pharma industry urges UK to spend more R&D infrastructure

3 September 2019
abpi_logo_large-1--1

As the UK’s finance minister prepares to outline the government’s spending plans for the coming period, the pharma industry has urged greater ambition in a number of key areas.

Chancellor of the Exchequer Sajid Javid has said he plans to concentrate on “schools, hospitals and police,” as priority areas for increased spending.

Meanwhile, leading trade body the Association of the British Pharmaceutical Industry (ABPI) urged the government to focus on infrastructure and science, as well as addressing the skills gaps in the life sciences sector.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical